Do you have type 1 diabetes? Has your doctor told you that your HbA1c is higher than the goal? Do you also have excess body weight? If you are having a hard time controlling your blood sugar with only insulin, you may be able to participate in a research study to see if taking an investigational medication once weekly can help improve your blood sugar control and reduce your body weight.

We want to hear from you! If you are a college student, please take our quick survey. It will take about 15 minutes. We want to know how you feel about being part of our campus. Your answers are private. You can also enter to win a $20 Amazon gift card. We have 50 gift cards to give away! You don't have to do the survey to enter the raffle.

Do you want to help in the design of a new device that can electronically measure and track your strength? We are testing a new system that uses an electronic resistance exercise band and an 'app' designed for older adults to improve strength and prevent weakness. We will provide $25 in gift card incentives.

Feel anxious when your body goes into "fight or flight?" You may be eligible to participate in a research study to learn how difficult emotions, such as anxiety and fear, relate to feelings in the body. Compensation provided.

Has your partner ever used a gun to hurt or scare you? Have you ever filed for a protective order in North Carolina? If so, we'd like to talk to you about your experiences. Click the link to find out if you qualify for a research study about domestic violence protective orders and guns. Participation includes a phone interview and compensation is provided.

The purpose of this research is to test the safety of NXC-201 (a CAR-T cell targeting the BCMA protein) at different doses in participants with relapsed/refractory AL amyloidosis, and to confirm the best dose for further testing. In addition, the study will evaluate the effectiveness of NXC-201 in treating relapsed/refractory AL amyloidosis

The main purpose of this study is to explore how aging affects not only the local organization of hippocampus but also the corresponding global connectivity. Additionally, the findings of age-dependent alteration on hippocampal subfield networks lay the foundation for the development of an early biomarker of Alzheimer's disease.

The purpose of this study is to determine if epcoritamab can be used to treat patients with previously treated WM.

This study aims to evaluate the effectand safety of empasiprubart compared with intravenous immunoglobulin (IVIg) treatment in adults with multifocal motor neuropathy (MMN). This study will also check how empasiprubart affects the body, how it is absorbed and removed from the body, and how the immune system reacts to empasiprubart.

The goal of this interview is to gather a clinician's perspective on the feasibility and potential integration of a new Geriatric Functional Assessment System (GFAS) into their clinical practice. This proposed system is a clinic-based wearable device designed to collect visual and motion data from older adults during their primary care visits that will help assess physical function. Its goal is to collect and process data, apply machine learning, and enable clinicians to identify early signs of functional decline.